An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy.
Saved in:
| Title: | An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy. |
|---|---|
| Authors: | Chan S; AbbVie Redwood City, Redwood City, CA, USA., Belmar N; AbbVie Redwood City, Redwood City, CA, USA., Ho S; AbbVie Redwood City, Redwood City, CA, USA., Rogers B; AbbVie Redwood City, Redwood City, CA, USA., Stickler M; Calico Labs, South San Francisco, CA, USA., Graham M; AbbVie Redwood City, Redwood City, CA, USA., Lee E; AbbVie Redwood City, Redwood City, CA, USA., Tran N; AbbVie Redwood City, Redwood City, CA, USA., Zhang D; AbbVie Redwood City, Redwood City, CA, USA., Gupta P; Seattle Genetics, South San Francisco, CA, USA., Sho M; AbbVie Redwood City, Redwood City, CA, USA., MacDonough T; Atomwise, San Francisco, CA, USA., Woolley A; Bristol Myers Squibb, Redwood City, CA, USA., Kim H; Bolt Biotherapeutics, Inc., Redwood City, CA, USA., Zhang H; Sanofi, Cambridge, MA, USA., Liu W; AbbVie Redwood City, Redwood City, CA, USA., Zheng P; AbbVie Redwood City, Redwood City, CA, USA., Dezso Z; AbbVie Redwood City, Redwood City, CA, USA., Halliwill K; AbbVie Redwood City, Redwood City, CA, USA., Ceccarelli M; University of Naples Federico II, Naples, Italy., Rhodes S; AbbVie Redwood City, Redwood City, CA, USA., Thakur A; AbbVie Redwood City, Redwood City, CA, USA., Forsyth CM; AbbVie Redwood City, Redwood City, CA, USA., Xiong M; AbbVie Redwood City, Redwood City, CA, USA., Tan SS; AbbVie Redwood City, Redwood City, CA, USA., Iyer R; AbbVie, Inc., North Chicago, IL, USA., Lake M; AbbVie, Inc., North Chicago, IL, USA., Digiammarino E; AbbVie, Inc., North Chicago, IL, USA., Zhou L; AbbVie Bioresearch Center, Worcester, MA, USA., Bigelow L; AbbVie, Inc., North Chicago, IL, USA., Longenecker K; AbbVie, Inc., North Chicago, IL, USA., Judge RA; AbbVie, Inc., North Chicago, IL, USA., Liu C; AbbVie Bioresearch Center, Worcester, MA, USA., Trumble M; AbbVie Bioresearch Center, Worcester, MA, USA., Remis JP; Former Department of Molecular Biosciences, Northwestern University, Evanston, IL, USA.; California Institute for Quantitative Biosciences, University of California, Berkeley, CA, USA., Fox M; AbbVie Redwood City, Redwood City, CA, USA., Cairns B; Oxford Biotherapeutics, San Jose, CA, USA., Akamatsu Y; AbbVie Redwood City, Redwood City, CA, USA., Hollenbaugh D; Good Therapeutics, Inc., Seattle, WA, USA., Harding F; Calico Labs, South San Francisco, CA, USA., Alvarez HM; AbbVie Redwood City, Redwood City, CA, USA. hamsell.alvarezjares@abbvie.com. |
| Source: | Nature cancer [Nat Cancer] 2022 Mar; Vol. 3 (3), pp. 337-354. Date of Electronic Publication: 2022 Mar 07. |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35256819 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chan+S%22">Chan S</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Belmar+N%22">Belmar N</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ho+S%22">Ho S</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rogers+B%22">Rogers B</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Stickler+M%22">Stickler M</searchLink>; Calico Labs, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Graham+M%22">Graham M</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+E%22">Lee E</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tran+N%22">Tran N</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+D%22">Zhang D</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+P%22">Gupta P</searchLink>; Seattle Genetics, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sho+M%22">Sho M</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22MacDonough+T%22">MacDonough T</searchLink>; Atomwise, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Woolley+A%22">Woolley A</searchLink>; Bristol Myers Squibb, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+H%22">Kim H</searchLink>; Bolt Biotherapeutics, Inc., Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; Sanofi, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+W%22">Liu W</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zheng+P%22">Zheng P</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Dezso+Z%22">Dezso Z</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Halliwill+K%22">Halliwill K</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ceccarelli+M%22">Ceccarelli M</searchLink>; University of Naples Federico II, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Rhodes+S%22">Rhodes S</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Thakur+A%22">Thakur A</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Forsyth+CM%22">Forsyth CM</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Xiong+M%22">Xiong M</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tan+SS%22">Tan SS</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Iyer+R%22">Iyer R</searchLink>; AbbVie, Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Lake+M%22">Lake M</searchLink>; AbbVie, Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Digiammarino+E%22">Digiammarino E</searchLink>; AbbVie, Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+L%22">Zhou L</searchLink>; AbbVie Bioresearch Center, Worcester, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bigelow+L%22">Bigelow L</searchLink>; AbbVie, Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Longenecker+K%22">Longenecker K</searchLink>; AbbVie, Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Judge+RA%22">Judge RA</searchLink>; AbbVie, Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Liu+C%22">Liu C</searchLink>; AbbVie Bioresearch Center, Worcester, MA, USA.<br /><searchLink fieldCode="AU" term="%22Trumble+M%22">Trumble M</searchLink>; AbbVie Bioresearch Center, Worcester, MA, USA.<br /><searchLink fieldCode="AU" term="%22Remis+JP%22">Remis JP</searchLink>; Former Department of Molecular Biosciences, Northwestern University, Evanston, IL, USA.; California Institute for Quantitative Biosciences, University of California, Berkeley, CA, USA.<br /><searchLink fieldCode="AU" term="%22Fox+M%22">Fox M</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cairns+B%22">Cairns B</searchLink>; Oxford Biotherapeutics, San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Akamatsu+Y%22">Akamatsu Y</searchLink>; AbbVie Redwood City, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hollenbaugh+D%22">Hollenbaugh D</searchLink>; Good Therapeutics, Inc., Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Harding+F%22">Harding F</searchLink>; Calico Labs, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Alvarez+HM%22">Alvarez HM</searchLink>; AbbVie Redwood City, Redwood City, CA, USA. hamsell.alvarezjares@abbvie.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101761119%22">Nature cancer</searchLink> [Nat Cancer] 2022 Mar; Vol. 3 (3), pp. 337-354. <i>Date of Electronic Publication: </i>2022 Mar 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101761119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2662-1347 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226621347%22">26621347 </searchLink><i>NLM ISO Abbreviation: </i>Nat Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35256819 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s43018-022-00334-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 337 Titles: – TitleFull: An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chan S – PersonEntity: Name: NameFull: Belmar N – PersonEntity: Name: NameFull: Ho S – PersonEntity: Name: NameFull: Rogers B – PersonEntity: Name: NameFull: Stickler M – PersonEntity: Name: NameFull: Graham M – PersonEntity: Name: NameFull: Lee E – PersonEntity: Name: NameFull: Tran N – PersonEntity: Name: NameFull: Zhang D – PersonEntity: Name: NameFull: Gupta P – PersonEntity: Name: NameFull: Sho M – PersonEntity: Name: NameFull: MacDonough T – PersonEntity: Name: NameFull: Woolley A – PersonEntity: Name: NameFull: Kim H – PersonEntity: Name: NameFull: Zhang H – PersonEntity: Name: NameFull: Liu W – PersonEntity: Name: NameFull: Zheng P – PersonEntity: Name: NameFull: Dezso Z – PersonEntity: Name: NameFull: Halliwill K – PersonEntity: Name: NameFull: Ceccarelli M – PersonEntity: Name: NameFull: Rhodes S – PersonEntity: Name: NameFull: Thakur A – PersonEntity: Name: NameFull: Forsyth CM – PersonEntity: Name: NameFull: Xiong M – PersonEntity: Name: NameFull: Tan SS – PersonEntity: Name: NameFull: Iyer R – PersonEntity: Name: NameFull: Lake M – PersonEntity: Name: NameFull: Digiammarino E – PersonEntity: Name: NameFull: Zhou L – PersonEntity: Name: NameFull: Bigelow L – PersonEntity: Name: NameFull: Longenecker K – PersonEntity: Name: NameFull: Judge RA – PersonEntity: Name: NameFull: Liu C – PersonEntity: Name: NameFull: Trumble M – PersonEntity: Name: NameFull: Remis JP – PersonEntity: Name: NameFull: Fox M – PersonEntity: Name: NameFull: Cairns B – PersonEntity: Name: NameFull: Akamatsu Y – PersonEntity: Name: NameFull: Hollenbaugh D – PersonEntity: Name: NameFull: Harding F – PersonEntity: Name: NameFull: Alvarez HM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2022 Mar Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2662-1347 Numbering: – Type: volume Value: 3 – Type: issue Value: 3 Titles: – TitleFull: Nature cancer Type: main |
| ResultId | 1 |